Search
Products
Community
Markets
News
Brokers
More
IN
Get started
Markets
/
Israel
/
ETF market
/
TCH.F142
/
Analysis
TC.NASDAQBIOILS
TCH.F142
Tel Aviv Stock Exchange
TCH.F142
Tel Aviv Stock Exchange
TCH.F142
Tel Aviv Stock Exchange
TCH.F142
Tel Aviv Stock Exchange
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
Discussions
Technicals
Seasonals
Key stats
Assets under management (AUM)
8.93 M
ILS
Fund flows (1Y)
−192.94 M
ILS
Dividend yield (indicated)
—
Discount/Premium to NAV
0.5%
Shares outstanding
248.95 K
Expense ratio
0.30%
About TC.NASDAQBIOILS
Issuer
Meitav Investment House Ltd.
Brand
Tachlit
Home page
tase.co.il
Inception date
Nov 27, 2018
Index tracked
NASDAQ Biotechnology Index
Replication method
Physical
Management style
Passive
Primary advisor
Meitav Mutual Funds Ltd.
ISIN
IL0011448649
The fund's goal try to achieve results as similar as possible to the rate of change in the index of change in the exchange rate of the US dollar.
Show more
Classification
Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Exchange-specific
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
What's in the fund
As of October 31, 2024
Exposure type
Bonds, Cash & Other
Government
Cash
Bonds, Cash & Other
100.00%
Government
74.07%
Cash
28.39%
ETF
1.00%
Miscellaneous
−3.47%
Stock breakdown by region
100%
North America
100.00%
Latin America
0.00%
Europe
0.00%
Asia
0.00%
Africa
0.00%
Middle East
0.00%
Oceania
0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows